James J Cunningham

Title: The Innovations of James J Cunningham

Introduction

James J Cunningham is a notable inventor based in Wayne, Pennsylvania. He has made significant contributions to the field of gene expression modulation, holding a total of nine patents. His work has implications for the diagnosis and treatment of various diseases and conditions.

Latest Patents

One of his latest patents focuses on RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA). This invention relates to compounds, compositions, and methods for studying, diagnosing, and treating traits, diseases, and conditions that respond to the modulation of gene expression. Specifically, it involves double-stranded nucleic acid molecules, including small nucleic acid molecules, such as siNA molecules, that can mediate RNA interference against target gene expression.

Career Highlights

Throughout his career, James J Cunningham has worked with prominent companies in the biotechnology sector. Notable among these are Sirna Therapeutics, Inc. and Merck Sharp & Dohme Corporation. His experience in these organizations has allowed him to advance his research and contribute to innovative solutions in gene therapy.

Collaborations

James has collaborated with several professionals in his field, including Matthew G Stanton and Steven M Stirdivant. These collaborations have enriched his work and expanded the impact of his inventions.

Conclusion

James J Cunningham's contributions to the field of gene expression modulation through his patents and collaborations highlight his role as a significant innovator. His work continues to influence the landscape of biotechnology and medical research.